Obstructive Sleep Apnea Associated With Cardiometabolic Risk Factors
Objective short sleep duration is associated with daytime sleepiness, whereas obstructive sleep apnea is associated with obesity, dyslipidemia, and hypertension.
Hypertension
Pulmonary Hypertension and Diabetes: Is There a Link?
For patients with type 1 and type 2 diabetes, the lung is often overlooked as a target organ.
Clinical Outcomes Compared With Generics, Brand-Name Drugs for Chronic Conditions
An analysis of data from over 3.5 million patients found comparable clinical outcomes among patients who initiated generics vs those who were treated with brand-name drugs for chronic conditions such as diabetes, hypertension, osteoporosis, depression and anxiety.
Smartphone App for Remotely Managing Hypertension Effective in T2D
Remote blood pressure monitoring by a smartphone app effectively reduces systolic blood pressure at 6 weeks.
AHA Issues Scientific Statement on Accurate Blood Pressure Readings
The American Heart Association has updated its scientific statement on blood pressure readings.
LDL-C Levels May Not Affect CVD Event Risk in Certain Patients With Hypertension
Researchers evaluated the relationship between low-density lipoprotein cholesterol and cardiovascular outcomes in patients with hypertension at increased cardiovascular risk.
Comorbid Metabolic Syndrome, Psoriatic Arthritis Linked to Reduced Health-Related Quality of Life
Patients with plaque psoriasis have a reduced health-related quality of life, mainly in terms of emotional aspects.
Cardiovascular Comorbidity Screening Should Be Conducted in COPD With Obesity
Hypertension and diabetes are especially prevalent comorbidities in obese patients with chronic obstructive pulmonary disease.
Primary Hypertension May Not Affect Prognosis of Postmenopausal Osteoporosis
The presence of primary hypertension does not appear to have an effect on the prognosis of postmenopausal osteoporosis.
Reducing Systolic Blood Pressure With Liraglutide: Predictors and Correlates
Patients with type 2 diabetes treated with liraglutide experience a greater reduction in systolic BP if they have lower baseline continuous glucose monitoring values and higher diastolic BP.
Next post in Type 2 Diabetes
